Uriclense 500

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Vaccinium macrocarpon, Quantity: 500 mg (Equivalent: Vaccinium macrocarpon, Qty 25 g)

Available from:

Arrotex Pharmaceuticals Pty Ltd

Pharmaceutical form:

Tablet, effervescent

Composition:

Excipient Ingredients: sodium bicarbonate; tartaric acid; citric acid; sorbitol; saccharin sodium; macrogol 6000; colloidal anhydrous silica

Administration route:

Oral

Therapeutic indications:

Antioxidant/Reduce free radicals formed in the body ; Maintain/support bladder health ; Traditionally used in Western herbal medicine to Helps reduce occurrence of medically diagnosed cystitis ; Maintain/support urinary tract health ; Traditionally used in Western herbal medicine to Maintain/support urinary tract health ; Maintain/support urinary tract function

Product summary:

Visual Identification: ;

Authorization status:

Listed

Authorization date:

2020-12-07